/Investor DB

Nextech Invest — 2022 Investments

2 investments dated 2022 · listed companies and verified rows first · show all

Alpha-9 Theranostics Inc.alpha9tx.cominDec 2022

Alpha-9 is a clinical-stage radiopharmaceutical company developing a portfolio of targeted molecules to treat cancer cells with precision.

BiotechLongevityMedical DevicesBoston, US

Co-investorsFrazier Life SciencesWUTIF CapitalAscenta CapitalBiotechnology Value FundLightspeed Venture PartnersLongitude Capital+1 more

MOMA Therapeuticsmomatx.comin𝕏May 2022 · $150M

A drug discovery company staffed by scientists and industry specialists focused on developing pharmaceutical candidates.

Biotech

Timur Yusufzai(Founder)inAsit Parikh(Chief Executive Officer)in

Co-investorsLifeSci Venture PartnersThird Rock VenturesAlexandriaCasdin CapitalCreacion VenturesGoldman Sachs+4 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.